Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) EPS (Basic) (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of EPS (Basic) data on record, last reported at -$0.26 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 18.75% year-over-year to -$0.26; the TTM value through Dec 2025 reached -$1.08, down 18.68%, while the annual FY2025 figure was -$1.08, 17.39% down from the prior year.
  • EPS (Basic) reached -$0.26 in Q4 2025 per PLSE's latest filing, up from -$0.28 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.18 in Q3 2023 and bottomed at -$0.71 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$0.34, with a median of -$0.27 recorded in 2025.
  • Peak YoY movement for EPS (Basic): surged 63.27% in 2023, then tumbled 52.38% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.51 in 2021, then skyrocketed by 56.86% to -$0.22 in 2022, then increased by 4.55% to -$0.21 in 2023, then crashed by 52.38% to -$0.32 in 2024, then rose by 18.75% to -$0.26 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were -$0.26 in Q4 2025, -$0.28 in Q3 2025, and -$0.29 in Q2 2025.